DXd ADC Technology: Delivering the Potential of ADCs

แชร์
ฝัง
  • เผยแพร่เมื่อ 30 ม.ค. 2025
  • This video is intended for U.S. HCPs only.
    Discover the components behind our proprietary DXd ADC Technology that aids in the delivery and activity of the antibody drug conjugates (ADCs) within #cancer cells. At Daiichi Sankyo, we seek to make bold strides in #oncology therapy in order to help people impacted by cancer around the world. Explore our DXd ADC Technology in greater detail here: bit.ly/3qKHi5w

ความคิดเห็น •